Steroid hormones for contraception in women with sickle cell disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Manchikanti, Anu ^a   Grimes, D A ^b   Lopez, L M ^b   Schulz, K F ^b  

^a Clinical Research Department   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; PLACEBO; STEROID HORMONE;

CLINICAL PROTOCOL; CONFIDENCE INTERVAL; CONTRACEPTION; DATA BASE; DISEASE SEVERITY; FOLLOW UP; HUMAN; OUTCOME ASSESSMENT; REVIEW; SICKLE CELL ANEMIA;

EID: 42749101900     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006261     Document Type: Review

References (15)

1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. The use of hormonal contraception in women with co-existing medical conditions. International Journal of Gynaecology and Obstetrics 2001;75:93-106.
2. Anonymous. New survey findings. The reproductive revolution continues. Population Reports, Series M 2003;17:1-42.
3. Blumenstein BA, Douglas MB, Hall WD. Blood pressure changes and oral contraceptive use: a study of 2676 black women in the southeastern United States. American Journal of Epidemiology 1980;112:539-52.
4. Foster HW. Contraceptives in sickle cell disease. Southern Medical Journal 1981;74:543-5.
5. Freie HM. Sickle cell diseases and hormonal contraception. Acta Obstetricia et Gynecologica Scandinavica 1983;62:211-7.
6. Goldzieher JW, Zamah NM. Oral contraceptive side effects: where's the beef?. Contraception 1995;52:327-35.
7. Gray RH, Wawer MJ, Serwadda D, Sewankambo N, Li C, Wabwire-Mangen F, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998;351:98-103.
8. Howard RJ, Lillis C, Tuck SM. Contraceptives, counselling, and pregnancy in women with sickle cell disease. British Medical Journal 1993;306:1735-7.
9. Lutcher CL, Harris P, Henderson PA, Milner PF. A lack of morbidity from oral contraception in women with sickle cell anemia. Clinical Research 1981;29:863A.
10. Lutcher CL, Milner PF. Contraceptive-induced vascular occlusive events in sickle cell disorders - fact or fiction?. Clinical Research 1986;34:217A.
11. Munker R, Hiller E, Paquette R. Modern hematology: biology and clinical management. Totowa, New Jersey: Humana Press, 2000.
12. Disease and Conditions Index. Bethesda (MD): National Heart, Lung, and Blood Institute; 2003.
13. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease - Life expectancy and risk factors for early death. New England Journal of Medicine 1994;330:1639-44.
14. Serjeant GR, Loy LL, Crowther M, Hambleton IR, Thame M. Outcome of pregnancy in homozygous sickle cell disease. Obstetrics and Gynecology 2004;103:1278-85.
15. World Health Organization. Medical eligibility criteria for contraceptive use. Geneva:World Health Organization, 2004.